Clinical Trialsbriefings.

Glowing molecular structures float above empty laboratory shelves, symbolizing abundant AI-driven discovery without regulatory proof.

AI Drug Discovery's Evidence Gap

Billions have flowed into AI drug discovery with zero FDA approvals, and the bottleneck is evidence infrastructure, not molecule generation.

A glowing network of light connects a laboratory vial to abstract molecular structures, symbolizing AI woven into drug discovery.

Clinical AI's Financial Case Is Made. Its Audit Trail Isn't.

Drug discovery and trial AI are proving their financial return faster than sponsors are building the validation records to defend that work at inspection.

Abstract image of diverse translucent human silhouettes woven with DNA strands, symbolizing demographic representation gaps in AI-driven drug discovery.

The Subgroup Blind Spot in Drug Discovery AI

As AI compresses drug discovery timelines, unrepresentative training data is emerging as a distinct liability separate from model performance or speed gains.